Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Status

UNKNOWN

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00416143

Enrollment

Registered

2006-12-27

Start date

2006-06-30

Completion date

2008-12-31

Last updated

2006-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Loss of Hearing

Keywords

Bed rest for idiopathic sudden sensorineural hearing loss

Brief summary

sudden sensorineural hearing loss: * idiopathic in most cases * 5-20/100,000 new cases annually in the U.S * no establishes pathogenesis * treated with oral steroids in most cases * \ 50% improvement in hearing levels * bed rest - acceptable treatment, not well investigated

Interventions

PROCEDUREbed rest

DRUGprednisone - oral corticosteroid 1mg/kg/D for 1 week

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with sudden sensorineural hearing loss

Exclusion criteria

* age less than 16 years * contraindication for oral steroid treatment * prior steroid treatment for hearing loss * pregnent women

Design outcomes

Primary

Measure	Time frame
hearing improvement	—

Countries

Israel

Contacts

Primary ContactEldar Carmel, MD

eldarca@sheba.health.gov.il972-3-5302442

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026